Transthyretin-related familial amyloidotic polyneuropathy-progress in kumamoto, Japan (1967-2010)-

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 86, Issue 7, 2010, Pages 694-706

  Araki, Shukuro ^a   Ando, Yukio ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Clinicopathology; Diagnostic tests; Epidemiology; Liver transplantation; Molecular genetics; Transthyretin related familial amyloidotic polyneuropathy (TTR related FAP)

Indexed keywords

PREALBUMIN;

CHEMISTRY; CITY; FAMILIAL AMYLOID POLYNEUROPATHY; GENETICS; HUMAN; JAPAN; LIVER TRANSPLANTATION; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

AMYLOID NEUROPATHIES, FAMILIAL; CITIES; HUMANS; JAPAN; LIVER TRANSPLANTATION; PREALBUMIN; PROGNOSIS;

EID: 77957880305     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.86.694     Document Type: Review

References (70)

1. Araki, S. (1984) Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev. 6, 128-133.
2. Benson, M.D. (1989) Familial amyloidotic polyneuropathy. Trends Neurosci. 12, 88-92.
3. Benson, M.D. and Uemichi, T. (1996) Transthyretin amyloidosis. Amyloid 3, 44-56.
4. Ando, Y., Araki, S. and Ando, M. (1993) Transthyretin related amyloidosis. Intern. Med. 32, 920-922.
5. Andrade, C. (1952) A peculiar form of peripheral neuropathy: Familial generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427.
6. Araki, S., Mawatari, S., Ohta, M., Nakajima, A. and Kuroiwa, Y. (1968) Polyneurotic amyloidosis in a Japanese family. Arch. Neurol. 18, 593-602.
7. Andersson, R. (1976) Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med. Scand. Suppl. 590, 1-64.
8. Ando, Y., Nakamura, M. and Araki, S. (2005) Transthyretin related familial amyloidotic polyneuropathy. Arch. Neurol. 62, 1057-1062.
9. Tashima, K., Ando, Y., Tanaka, Y., Uchino, M. and Ando, M. (1995) Change in the age of onset in patients with familial amyloidotic polyneuropathy type I. Intern. Med. 34, 748-750.
10. Benson, M.D. and Uemichi, T. (1996) Transthyretin amyloidosis. Amyloid 3, 44-56.
11. Connors, L.H., Lim, A., Prokaeva, T., Roskens, V.A. and Costello, C.E. (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 10, 160-185.
12. Goren, H., Steinberg, M.C. and Farboody, G.H. (1980) Familial oculoleptomeningeal amyloidosis. Brain 103, 473-495.
13. Kito, S., Itonaga, E., Kamiya, K., Kishida, T. and Yamamura, Y. (1980) Studies on familial amyloidotic polyneuropathy in Ogawa Village, Japan. Eur. Neurol. 19, 141-151.
14. Ikeda, S., Nakazato, M., Ando, Y. and Sobue, G. (2002) Familial amyloidotic polyneuropathy in Japan: Clinical and genetic heterogeneity. Neurology 58, 1001-1007.
15. Costa, P.P., Figueira, A.S. and Bravo, F.R. (1978) Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Natl. Acad. Sci. USA 75, 4499-4503.
16. Tawara, S., Nakazato, M., Kangawa, K., Matsuo, H. and Araki, S. (1983) Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem. Biophys. Res. Commun. 116, 880-888.
17. Asahara, K., Ando, Y., Tanaka, Y., Yi, S., Yamashita, T. and Ando, M. (1993) Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy. Acta Haematol. 90, 130-135.
18. Ando, E., Ando, Y., Okamura, R., Uchino, M., Ando, M. and Negi, A. (1997) Ocular manifestations of familial amyloidotic polyneuropathy type I: longterm follow up. Br. J. Ophthalmol. 81, 295-298.
19. Araki, S. (1982) Amyloidosis. Asian Med. J. 25, 89-92.
20. Nakamura, M., Yamashita, T., Ueda, M., Obayashi, K., Sato, T., Ikeda, T. et al. (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65, 1051-1056.
21. Terazaki, H., Ando, Y., Misumi, S., Nakamura, M., Ando, E., Matsunaga, N. et al. (1999) A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels. Biochem. Biophys. Res. Commun. 264, 365-370.
22. Arpa Gutiérrez, J., Morales, C., Lara, M., Muñoz, C., García-Rojo, M., Caminero, A. et al. (1993) Type I familial amyloid polyneuropathy and pontine haemorrhage. Acta Neuropathol. 86, 542-545.
23. Ushiyama, M., Ikeda, S. and Yanagihara, N. (1991) Transthyretin type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol. 81, 524-528.
24. Sakashita, N., Ando, Y., Jinnouchi, K., Yoshimatsu, M., Terazaki, H., Obayashi, K. et al. (2001) Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol. Int. 51, 476-480.
25. Sakashita, N., Ando, Y., Obayashi, K., Terazaki, H., Yamashita, T., Takeya, M. et al. (2000) Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report. Virchows Arch. 436, 345-350.
26. Murakami, T., Yi, S., Yamamoto, K., Maruyama, S. and Araki, S. (1992) Familial amyloidotic polyneuropathy: report of patients heterozygous for the transthyretin Gly42 gene. Ann. Neurol. 31, 340-342.
27. Murakami, T., Tachibana, S., Endo, Y., Kawai, R., Hara, M., Tanase, S. et al. (1994) Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 44, 315-318.
28. Murakami, T., Atsumi, T., Maeda, S., Tanase, S., Ishikawa, K., Mita, S. et al. (1992) A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy. Biochem. Biophys. Res. Commun. 187, 397-403.
29. Nakamura, M., Yamashita, T., Ando, Y., Asl, K.H., Tashima, K., Ohlsson, P.I. et al. (1999) Identification of a new transthyretin variant (ILe49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase cleavage assay. Hum. Hered. 49, 186-189.
30. Ando, Y., Ohtsu, Y., Terazaki, H., Kibayashi, K., Nakamura, M., Ando, E. et al. (2000) Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met). Amyloid 7, 133-136.
31. Bergström, J., Patrosso, M.C., Colussi, G., Salvadore, M., Penco, S., Lando, G. et al. (2007) A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of κ light chains. Amyloid 14, 141-145.
32. Takahashi, K., Yi, S., Kimura, Y. and Araki, S. (1991) Familial amyloidotic polyneuropathy type I in Kumamoto, Japan: a clinico-pathologic, histochemical, immunohistochemical, and ultrastructural study. Hum. Pathol. 22, 519-527.
33. Takahashi, K., Sakashita, N., Ando, Y., Suga, M. and Ando, M. (1997) Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type. Pathol. Int. 47, 353-359.
34. Araki, S. and Yi, S. (2000) Pathology of familial amyloidotic polyneuropathy with TTR met 30 in Kumamoto, Japan. Neuropathology 20 (Suppl), S47-S51.
35. McCutchen, S.L., Colon, W. and Kelley, J.W. (1993) Transthyretin mutation Leu-55-Pro alters tetrameric stability and increases amyloidogenicity. Biochemistry 32, 12119-12127.
36. Kelly, J.W. and Lansbury, P.T. Jr. (1994) A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid formation. Amyloid 1, 186-205.
37. Longo Alves, I., Hays, M.T. and Saraiva, M.J. (1997) Comparative stability and clearance of [Met30]-transthyretin and [Met119]transthyretin. Eur. J. Biochem. 249, 662-668.
38. Almedida, M.R., Alves, I.L., Terazaki, H., Ando, Y. and Saraiva, M.J. (2000) Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M. Biochem. Biophys. Res. Commun. 270, 1024-1028.
39. Alves, I.L., Divino, C.M., Schussler, G.C., Altland, K., Almeida, M.R., Palha, J.A. et al. (1993) Thyroxine binding in a TTR Met 119 kindred. J. Clin. Endocrinol. Metab. 77, 484-488.
40. Almeida, M.R., Damas, A.M., Lans, M.C., Brouwer, A. and Saraiva, M.J. (1997) Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis. Endocrine 6, 309-315.
41. Baures, P.W., Oza, V.B., Peterson, S.A. and Kelly, J.W. (1999) Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg. Med. Chem. 7, 1339-1347.
42. Tojo, K., Sekijima, Y., Kelly, J.W. and Ikeda, S. (2006) Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci. Res. 56, 441-449.
43. Sekijima, Y., Kelly, J.W. and Ikeda, S. (2008) Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des. 14, 3219-3230.
44. Sato, T., Ando, Y., Susuki, S., Mikami, F., Ikemizu, S., Nakamura, M. et al. (2006) Chromium (III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation. FEBS Lett. 580, 491-496.
45. Pater, M. (2009) Spotlight focuses on protein-misfolding thera. Nat. Biotechnol. 27, 874.
46. Tsuzuki, T., Mita, S., Maeda, S., Araki, S. and Shimada, K. (1985) Structure of the human prealbumin gene. J. Biol. Chem. 260, 12224-12227.
47. Mita, S., Maeda, S., Shimada, K. and Araki, S. (1984) Cloning and sequence analysis of cDNA for human prealbumin. Biochem. Biophys. Res. Commun. 124, 558-564.
48. Mita, S., Maeda, S., Ide, M., Tsuzuki, T., Shimada, K. and Araki, S. (1986) Familial amyloidotic polyneuropathy diagnosed by cloned human prealbumin cDNA. Neurology 36, 298-301.
49. Herbert, J., Wilcox, J.N., Pham, K.T., Fremeau, R.T. Jr., Zeviani, M., Dwork, A. et al. (1986) Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell Award. Neurology 36, 900-911.
50. Jacobsson, B., Carlström, A., Platz, A. and Collins, V.P. (1990) Transthyretin messenger ribonucleic acid expression in the pancreas and in endocrine tumors of the pancreas and gut. J. Clin. Endocrinol. Metab. 71, 875-880.
51. Shimada, K., Maeda, S., Murakami, T., Nishiguchi, S., Tashiro, F., Yi, S. et al. (1989) Transgenic mouse model of familial amyloidotic polyneuropathy. Mol. Biol. Med. 6, 333-343.
52. Yi, S., Takahashi, K., Naito, M., Tashiro, F., Wakasugi, S., Maeda, S. et al. (1991) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am. J. Pathol. 138, 403-412.
53. Murakami, T., Yi, S., Maeda, S., Tashiro, F., Yamamura, K., Takahashi, K. et al. (1992) Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Am. J. Pathol. 141, 451-456.
54. Ueda, M., Ando, Y., Hakamata, Y., Nakamura, M., Yamashita, T., Obayashi, K. et al. (2007) A novel transgenic rat with human amyloidogenic transthyretin V30M. Biochem. Biophys. Res. Commun. 352, 299-304.
55. Ando, Y., Ohlsson, P.I., Suhr, O., Nyhlin, N., Yamashita, T., Holmgren, G. et al. (1996) A new simple and rapid screening method for variant transthyretin (TTR) related amyloidosis. Biochem. Biophys. Res. Commun. 228, 480-483.
56. Ranlov, I., Ando, Y., Ohlsson, P.I., Holmgren, G., Ranlov, P.J. and Suhr, O.B. (1997) Rapid screening for amyloid-related variant forms of transthyretin is possible by electrospray ionization mass spectrometry. Eur. J. Clin. Invest. 27, 956-959.
57. Ueda, M., Misumi, Y., Mizuguchi, M., Nakamura, M., Yamashita, T., Sekijima, Y. et al. (2009) SELDI-TOF Mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin. Chem. 55, 1223-1227.
58. Ando, Y., Anan, I., Suhr, O., Holmgren, G. and Costa, P.M. (1998) Detection of a variant protein in hair: new diagnostic method in Portuguese type familial amyloid polyneuropathy. BMJ 316, 1500-1501.
59. Ando, E., Ando, Y., Maruoka, S., Sakai, Y., Watanabe, S., Yamashita, R. et al. (1992) Ocular microangiopathy in familial amyloidotic polyneuropathy, type I. Graefes Arch. Clin. Exp. Ophthalmol. 230, 1-5.
60. Holmgren, G., Costa, P.M., Andersson, C., Asplund, K., Steen, L., Beckman, L. et al. (1994) Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J. Med. Genet. 31, 351-354.
61. Continho, P., Macedo, E., Estacio, A., Saraiva, A., Costa, P.P. and Saraiva, M.J.M. (1988) Periodic plasma exchanges in treatment of familial amyloid polyneuropathy: Preliminary results. In Amyloid and Amyloidosis. (eds. Isobe, T., Araki, S., Uchino, F., Kito, S. and Tsubura, E.). Plenum Press, New York, pp. 845-849.
62. Ericzon, B.G., Holmgren, G., Lundgren, E. and Suhr, O.B. (1999) New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umea Sweden, June 1999. Amyloid 7, 145-147.
63. Skinner, M., Lewis, W.D., Jones, L.A., Kasirsky, J., Kane, K., Ju, S.T. et al. (1994) Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann. Intern. Med. 120, 133-134.
64. Takei, Y., Ikeda, S., Hashikura, Y., Ikegami, T. and Kawasaki, S. (1999) Partial-liver transplantation to treat familial amyloid polyneuropathy: Followup of 11 patients. Ann. Intern. Med. 131, 592-595.
65. Ando, Y., Tanaka, Y., Ando, E., Yamashita, T., Nishida, Y., Tashima, K. et al. (1995) Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 345, 195-196.
66. Suhr, O., Danielsson, A., Rydh, A., Nyhlin, N., Hietala, S.O. and Steen, L. (1996) Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig. Dis. Sci. 41, 1909-1914.
67. Lendoire, J., Trigo, P., Aziz, H., Cueto, G., Ando, Y., Tashima, K. et al. (1999) Liver transplantation in transthyretin familial amyloid polyneuropathy: First report from Argentina. Amyloid 6, 297-300.
68. Ando, Y., Terazaki, H., Haraoka, K., Tajiri, T., Nakamura, M., Obayashi, K. et al. (2002) Presence of autoantibody against ATTRVal30Met after sequential liver transplantation. Transplantation 73, 674-675.
69. Stangou, A.J. and Hawkins, P.N. (2004) Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr. Opin. Neurol. 17, 615-620.
70. Goto, T., Yamashita, T., Ueda, M., Ohshima, S., Yoneyama, K., Nakamura, M. et al. (2006) Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. Am. J. Transplant. 6, 2512-2515.